These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16233861)

  • 1. Note in statistical treatment of medical and pharmaceutical data.
    Kawase M; Konishi H; Yagi K; Nishikiori R; Takagi T
    J Biosci Bioeng; 2005 Jul; 100(1):116-8. PubMed ID: 16233861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confidence intervals for an exposure adjusted incidence rate difference with applications to clinical trials.
    Liu GF; Wang J; Liu K; Snavely DB
    Stat Med; 2006 Apr; 25(8):1275-86. PubMed ID: 16138360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exact, distribution free confidence intervals for late effects in censored matched pairs.
    Daniel SR
    Biom J; 2009 Feb; 51(1):31-44. PubMed ID: 19219909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parametric modelling of cost data: some simulation evidence.
    Briggs A; Nixon R; Dixon S; Thompson S
    Health Econ; 2005 Apr; 14(4):421-8. PubMed ID: 15685641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calculation of tolerance limits and sample size determination for clinical trials with dichotomous outcomes.
    Zaslavsky BG
    J Biopharm Stat; 2007; 17(3):481-91. PubMed ID: 17479395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An alternative to Cohen's standardized mean difference effect size: a robust parameter and confidence interval in the two independent groups case.
    Algina J; Keselman HJ; Penfield RD
    Psychol Methods; 2005 Sep; 10(3):317-28. PubMed ID: 16221031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confidence intervals for random effects meta-analysis and robustness to publication bias.
    Henmi M; Copas JB
    Stat Med; 2010 Dec; 29(29):2969-83. PubMed ID: 20963748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study on confidence intervals for incremental cost-effectiveness ratios.
    Wang H; Zhao H
    Biom J; 2008 Aug; 50(4):505-14. PubMed ID: 18663759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confidence interval construction for a difference between two dependent intraclass correlation coefficients.
    Ramasundarahettige CF; Donner A; Zou GY
    Stat Med; 2009 Mar; 28(7):1041-53. PubMed ID: 19142855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing treatment effects in unconfounded studies under model misspecification: logistic regression, discretization, and their combination.
    Cangul MZ; Chretien YR; Gutman R; Rubin DB
    Stat Med; 2009 Sep; 28(20):2531-51. PubMed ID: 19572258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample size and the probability of a successful trial.
    Chuang-Stein C
    Pharm Stat; 2006; 5(4):305-9. PubMed ID: 17128428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robustness of a parametric model for informatively censored bivariate longitudinal data under misspecification of its distributional assumptions: A simulation study.
    Pantazis N; Touloumi G
    Stat Med; 2007 Dec; 26(30):5473-85. PubMed ID: 18058854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple comparisons distortions of parameter estimates.
    Jeffries NO
    Biostatistics; 2007 Apr; 8(2):500-4. PubMed ID: 16971376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bootstrap-based test for establishing noninferiority in clinical trials.
    Chen M; Kianifard F; Dhar SK
    J Biopharm Stat; 2006 May; 16(3):357-63. PubMed ID: 16724490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonparametric empirical Bayes method for comparison of treatment effects with application to stress urinary incontinence data.
    Liu C; Shen W; Xie J
    Pharm Stat; 2008; 7(1):42-52. PubMed ID: 17311241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of changing the statistical methodology on hospital and surgeon ranking: the case of the New York State cardiac surgery report card.
    Glance LG; Dick A; Osler TM; Li Y; Mukamel DB
    Med Care; 2006 Apr; 44(4):311-9. PubMed ID: 16565631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonparametric confidence intervals for Tmax in sequence-stratified crossover studies.
    Willavize SA; Morgenthien EA
    Pharm Stat; 2008; 7(1):9-19. PubMed ID: 17256803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling and inference for an ordinal effect size measure.
    Ryu E; Agresti A
    Stat Med; 2008 May; 27(10):1703-17. PubMed ID: 17918752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confidence intervals of effect size for paired studies.
    Wu J; Jiang G
    Biom J; 2007 Aug; 49(5):765-73. PubMed ID: 17634978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confidence intervals and controlled clinical trials: incompatible tools for medical research.
    Hall DB
    J Biopharm Stat; 1993 Sep; 3(2):257-63. PubMed ID: 8220408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.